Global G-CSF and G-CSF Biosimilars Market Growth 2022-2028
- LP 4788424
- 109 Pages
- January 2022
- Pharmaceuticals
The United States G-CSF and G-CSF Biosimilars market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global G-CSF and G-CSF Biosimilars market, reaching US$ million by the year 2028. As for the Europe G-CSF and G-CSF Biosimilars landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main G-CSF and G-CSF Biosimilars players cover Pfizer, Novartis, Roche, and Merck & Co., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of G-CSF and G-CSF Biosimilars market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global G-CSF and G-CSF Biosimilars Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for G-CSF and G-CSF Biosimilars by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for G-CSF and G-CSF Biosimilars by Country/Region, 2017, 2022 & 2028
2.2 G-CSF and G-CSF Biosimilars Segment by Type
2.2.1 Blood Disorders
2.2.2 Oncology Diseases
2.2.3 Chronic And Autoimmune Diseases
2.2.4 Growth Hormone Deficiencies
2.3 G-CSF and G-CSF Biosimilars Sales by Type
2.3.1 Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2022)
2.3.2 Global G-CSF and G-CSF Biosimilars Revenue and Market Share by Type (2017-2022)
2.3.3 Global G-CSF and G-CSF Biosimilars Sale Price by Type (2017-2022)
2.4 G-CSF and G-CSF Biosimilars Segment by Application
2.4.1 Human Growth Hormone
2.4.2 Erythropoietin
2.4.3 Monoclonal Antibodies
2.4.4 Insulin
2.4.5 Interferon
2.5 G-CSF and G-CSF Biosimilars Sales by Application
2.5.1 Global G-CSF and G-CSF Biosimilars Sale Market Share by Application (2017-2022)
2.5.2 Global G-CSF and G-CSF Biosimilars Revenue and Market Share by Application (2017-2022)
2.5.3 Global G-CSF and G-CSF Biosimilars Sale Price by Application (2017-2022)
3 Global G-CSF and G-CSF Biosimilars by Company
3.1 Global G-CSF and G-CSF Biosimilars Breakdown Data by Company
3.1.1 Global G-CSF and G-CSF Biosimilars Annual Sales by Company (2020-2022)
3.1.2 Global G-CSF and G-CSF Biosimilars Sales Market Share by Company (2020-2022)
3.2 Global G-CSF and G-CSF Biosimilars Annual Revenue by Company (2020-2022)
3.2.1 Global G-CSF and G-CSF Biosimilars Revenue by Company (2020-2022)
3.2.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Company (2020-2022)
3.3 Global G-CSF and G-CSF Biosimilars Sale Price by Company
3.4 Key Manufacturers G-CSF and G-CSF Biosimilars Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers G-CSF and G-CSF Biosimilars Product Location Distribution
3.4.2 Players G-CSF and G-CSF Biosimilars Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for G-CSF and G-CSF Biosimilars by Geographic Region
4.1 World Historic G-CSF and G-CSF Biosimilars Market Size by Geographic Region (2017-2022)
4.1.1 Global G-CSF and G-CSF Biosimilars Annual Sales by Geographic Region (2017-2022)
4.1.2 Global G-CSF and G-CSF Biosimilars Annual Revenue by Geographic Region
4.2 World Historic G-CSF and G-CSF Biosimilars Market Size by Country/Region (2017-2022)
4.2.1 Global G-CSF and G-CSF Biosimilars Annual Sales by Country/Region (2017-2022)
4.2.2 Global G-CSF and G-CSF Biosimilars Annual Revenue by Country/Region
4.3 Americas G-CSF and G-CSF Biosimilars Sales Growth
4.4 APAC G-CSF and G-CSF Biosimilars Sales Growth
4.5 Europe G-CSF and G-CSF Biosimilars Sales Growth
4.6 Middle East & Africa G-CSF and G-CSF Biosimilars Sales Growth
5 Americas
5.1 Americas G-CSF and G-CSF Biosimilars Sales by Country
5.1.1 Americas G-CSF and G-CSF Biosimilars Sales by Country (2017-2022)
5.1.2 Americas G-CSF and G-CSF Biosimilars Revenue by Country (2017-2022)
5.2 Americas G-CSF and G-CSF Biosimilars Sales by Type
5.3 Americas G-CSF and G-CSF Biosimilars Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC G-CSF and G-CSF Biosimilars Sales by Region
6.1.1 APAC G-CSF and G-CSF Biosimilars Sales by Region (2017-2022)
6.1.2 APAC G-CSF and G-CSF Biosimilars Revenue by Region (2017-2022)
6.2 APAC G-CSF and G-CSF Biosimilars Sales by Type
6.3 APAC G-CSF and G-CSF Biosimilars Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe G-CSF and G-CSF Biosimilars by Country
7.1.1 Europe G-CSF and G-CSF Biosimilars Sales by Country (2017-2022)
7.1.2 Europe G-CSF and G-CSF Biosimilars Revenue by Country (2017-2022)
7.2 Europe G-CSF and G-CSF Biosimilars Sales by Type
7.3 Europe G-CSF and G-CSF Biosimilars Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa G-CSF and G-CSF Biosimilars by Country
8.1.1 Middle East & Africa G-CSF and G-CSF Biosimilars Sales by Country (2017-2022)
8.1.2 Middle East & Africa G-CSF and G-CSF Biosimilars Revenue by Country (2017-2022)
8.2 Middle East & Africa G-CSF and G-CSF Biosimilars Sales by Type
8.3 Middle East & Africa G-CSF and G-CSF Biosimilars Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of G-CSF and G-CSF Biosimilars
10.3 Manufacturing Process Analysis of G-CSF and G-CSF Biosimilars
10.4 Industry Chain Structure of G-CSF and G-CSF Biosimilars
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 G-CSF and G-CSF Biosimilars Distributors
11.3 G-CSF and G-CSF Biosimilars Customer
12 World Forecast Review for G-CSF and G-CSF Biosimilars by Geographic Region
12.1 Global G-CSF and G-CSF Biosimilars Market Size Forecast by Region
12.1.1 Global G-CSF and G-CSF Biosimilars Forecast by Region (2023-2028)
12.1.2 Global G-CSF and G-CSF Biosimilars Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global G-CSF and G-CSF Biosimilars Forecast by Type
12.7 Global G-CSF and G-CSF Biosimilars Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer G-CSF and G-CSF Biosimilars Product Offered
13.1.3 Pfizer G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis G-CSF and G-CSF Biosimilars Product Offered
13.2.3 Novartis G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche G-CSF and G-CSF Biosimilars Product Offered
13.3.3 Roche G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 Merck & Co.
13.4.1 Merck & Co. Company Information
13.4.2 Merck & Co. G-CSF and G-CSF Biosimilars Product Offered
13.4.3 Merck & Co. G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Merck & Co. Main Business Overview
13.4.5 Merck & Co. Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi G-CSF and G-CSF Biosimilars Product Offered
13.5.3 Sanofi G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson G-CSF and G-CSF Biosimilars Product Offered
13.6.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Gilead Science
13.7.1 Gilead Science Company Information
13.7.2 Gilead Science G-CSF and G-CSF Biosimilars Product Offered
13.7.3 Gilead Science G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Gilead Science Main Business Overview
13.7.5 Gilead Science Latest Developments
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Information
13.8.2 GlaxoSmithKline G-CSF and G-CSF Biosimilars Product Offered
13.8.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GlaxoSmithKline Main Business Overview
13.8.5 GlaxoSmithKline Latest Developments
13.9 AbbVie
13.9.1 AbbVie Company Information
13.9.2 AbbVie G-CSF and G-CSF Biosimilars Product Offered
13.9.3 AbbVie G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 AbbVie Main Business Overview
13.9.5 AbbVie Latest Developments
13.10 Amgen
13.10.1 Amgen Company Information
13.10.2 Amgen G-CSF and G-CSF Biosimilars Product Offered
13.10.3 Amgen G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Amgen Main Business Overview
13.10.5 Amgen Latest Developments
13.11 AstraZeneca
13.11.1 AstraZeneca Company Information
13.11.2 AstraZeneca G-CSF and G-CSF Biosimilars Product Offered
13.11.3 AstraZeneca G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 AstraZeneca Main Business Overview
13.11.5 AstraZeneca Latest Developments
13.12 Bayer
13.12.1 Bayer Company Information
13.12.2 Bayer G-CSF and G-CSF Biosimilars Product Offered
13.12.3 Bayer G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Bayer Main Business Overview
13.12.5 Bayer Latest Developments
14 Research Findings and Conclusion
Table 1. G-CSF and G-CSF Biosimilars Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. G-CSF and G-CSF Biosimilars Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Blood Disorders
Table 4. Major Players of Oncology Diseases
Table 5. Major Players of Chronic And Autoimmune Diseases
Table 6. Major Players of Growth Hormone Deficiencies
Table 7. Global G-CSF and G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
Table 8. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2022)
Table 9. Global G-CSF and G-CSF Biosimilars Revenue by Type (2017-2022) & ($ million)
Table 10. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2017-2022)
Table 11. Global G-CSF and G-CSF Biosimilars Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global G-CSF and G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
Table 13. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2022)
Table 14. Global G-CSF and G-CSF Biosimilars Revenue by Application (2017-2022)
Table 15. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2017-2022)
Table 16. Global G-CSF and G-CSF Biosimilars Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global G-CSF and G-CSF Biosimilars Sales by Company (2020-2022) & (K Units)
Table 18. Global G-CSF and G-CSF Biosimilars Sales Market Share by Company (2020-2022)
Table 19. Global G-CSF and G-CSF Biosimilars Revenue by Company (2020-2022) ($ Millions)
Table 20. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Company (2020-2022)
Table 21. Global G-CSF and G-CSF Biosimilars Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers G-CSF and G-CSF Biosimilars Producing Area Distribution and Sales Area
Table 23. Players G-CSF and G-CSF Biosimilars Products Offered
Table 24. G-CSF and G-CSF Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global G-CSF and G-CSF Biosimilars Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global G-CSF and G-CSF Biosimilars Sales Market Share Geographic Region (2017-2022)
Table 29. Global G-CSF and G-CSF Biosimilars Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global G-CSF and G-CSF Biosimilars Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global G-CSF and G-CSF Biosimilars Sales Market Share by Country/Region (2017-2022)
Table 33. Global G-CSF and G-CSF Biosimilars Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas G-CSF and G-CSF Biosimilars Sales by Country (2017-2022) & (K Units)
Table 36. Americas G-CSF and G-CSF Biosimilars Sales Market Share by Country (2017-2022)
Table 37. Americas G-CSF and G-CSF Biosimilars Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2017-2022)
Table 39. Americas G-CSF and G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
Table 40. Americas G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2022)
Table 41. Americas G-CSF and G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
Table 42. Americas G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2022)
Table 43. APAC G-CSF and G-CSF Biosimilars Sales by Region (2017-2022) & (K Units)
Table 44. APAC G-CSF and G-CSF Biosimilars Sales Market Share by Region (2017-2022)
Table 45. APAC G-CSF and G-CSF Biosimilars Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC G-CSF and G-CSF Biosimilars Revenue Market Share by Region (2017-2022)
Table 47. APAC G-CSF and G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
Table 48. APAC G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2022)
Table 49. APAC G-CSF and G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
Table 50. APAC G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2022)
Table 51. Europe G-CSF and G-CSF Biosimilars Sales by Country (2017-2022) & (K Units)
Table 52. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Country (2017-2022)
Table 53. Europe G-CSF and G-CSF Biosimilars Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2017-2022)
Table 55. Europe G-CSF and G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
Table 56. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2022)
Table 57. Europe G-CSF and G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
Table 58. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa G-CSF and G-CSF Biosimilars Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa G-CSF and G-CSF Biosimilars Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa G-CSF and G-CSF Biosimilars Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa G-CSF and G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa G-CSF and G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of G-CSF and G-CSF Biosimilars
Table 68. Key Market Challenges & Risks of G-CSF and G-CSF Biosimilars
Table 69. Key Industry Trends of G-CSF and G-CSF Biosimilars
Table 70. G-CSF and G-CSF Biosimilars Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. G-CSF and G-CSF Biosimilars Distributors List
Table 73. G-CSF and G-CSF Biosimilars Customer List
Table 74. Global G-CSF and G-CSF Biosimilars Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global G-CSF and G-CSF Biosimilars Sales Market Forecast by Region
Table 76. Global G-CSF and G-CSF Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global G-CSF and G-CSF Biosimilars Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas G-CSF and G-CSF Biosimilars Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas G-CSF and G-CSF Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC G-CSF and G-CSF Biosimilars Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC G-CSF and G-CSF Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe G-CSF and G-CSF Biosimilars Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe G-CSF and G-CSF Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa G-CSF and G-CSF Biosimilars Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa G-CSF and G-CSF Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global G-CSF and G-CSF Biosimilars Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global G-CSF and G-CSF Biosimilars Sales Market Share Forecast by Type (2023-2028)
Table 88. Global G-CSF and G-CSF Biosimilars Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global G-CSF and G-CSF Biosimilars Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global G-CSF and G-CSF Biosimilars Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global G-CSF and G-CSF Biosimilars Sales Market Share Forecast by Application (2023-2028)
Table 92. Global G-CSF and G-CSF Biosimilars Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global G-CSF and G-CSF Biosimilars Revenue Market Share Forecast by Application (2023-2028)
Table 94. Pfizer Basic Information, G-CSF and G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer G-CSF and G-CSF Biosimilars Product Offered
Table 96. Pfizer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Novartis Basic Information, G-CSF and G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 100. Novartis G-CSF and G-CSF Biosimilars Product Offered
Table 101. Novartis G-CSF and G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. Novartis Main Business
Table 103. Novartis Latest Developments
Table 104. Roche Basic Information, G-CSF and G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 105. Roche G-CSF and G-CSF Biosimilars Product Offered
Table 106. Roche G-CSF and G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Roche Main Business
Table 108. Roche Latest Developments
Table 109. Merck & Co. Basic Information, G-CSF and G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 110. Merck & Co. G-CSF and G-CSF Biosimilars Product Offered
Table 111. Merck & Co. G-CSF and G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. Merck & Co. Main Business
Table 113. Merck & Co. Latest Developments
Table 114. Sanofi Basic Information, G-CSF and G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 115. Sanofi G-CSF and G-CSF Biosimilars Product Offered
Table 116. Sanofi G-CSF and G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 117. Sanofi Main Business
Table 118. Sanofi Latest Developments
Table 119. Johnson & Johnson Basic Information, G-CSF and G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 120. Johnson & Johnson G-CSF and G-CSF Biosimilars Product Offered
Table 121. Johnson & Johnson G-CSF and G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 122. Johnson & Johnson Main Business
Table 123. Johnson & Johnson Latest Developments
Table 124. Gilead Science Basic Information, G-CSF and G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 125. Gilead Science G-CSF and G-CSF Biosimilars Product Offered
Table 126. Gilead Science G-CSF and G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 127. Gilead Science Main Business
Table 128. Gilead Science Latest Developments
Table 129. GlaxoSmithKline Basic Information, G-CSF and G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 130. GlaxoSmithKline G-CSF and G-CSF Biosimilars Product Offered
Table 131. GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 132. GlaxoSmithKline Main Business
Table 133. GlaxoSmithKline Latest Developments
Table 134. AbbVie Basic Information, G-CSF and G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 135. AbbVie G-CSF and G-CSF Biosimilars Product Offered
Table 136. AbbVie G-CSF and G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 137. AbbVie Main Business
Table 138. AbbVie Latest Developments
Table 139. Amgen Basic Information, G-CSF and G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 140. Amgen G-CSF and G-CSF Biosimilars Product Offered
Table 141. Amgen G-CSF and G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 142. Amgen Main Business
Table 143. Amgen Latest Developments
Table 144. AstraZeneca Basic Information, G-CSF and G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 145. AstraZeneca G-CSF and G-CSF Biosimilars Product Offered
Table 146. AstraZeneca G-CSF and G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 147. AstraZeneca Main Business
Table 148. AstraZeneca Latest Developments
Table 149. Bayer Basic Information, G-CSF and G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 150. Bayer G-CSF and G-CSF Biosimilars Product Offered
Table 151. Bayer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 152. Bayer Main Business
Table 153. Bayer Latest Developments
List of Figures
Figure 1. Picture of G-CSF and G-CSF Biosimilars
Figure 2. G-CSF and G-CSF Biosimilars Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global G-CSF and G-CSF Biosimilars Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global G-CSF and G-CSF Biosimilars Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. G-CSF and G-CSF Biosimilars Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Blood Disorders
Figure 10. Product Picture of Oncology Diseases
Figure 11. Product Picture of Chronic And Autoimmune Diseases
Figure 12. Product Picture of Growth Hormone Deficiencies
Figure 13. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type in 2021
Figure 14. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2017-2022)
Figure 15. G-CSF and G-CSF Biosimilars Consumed in Human Growth Hormone
Figure 16. Global G-CSF and G-CSF Biosimilars Market: Human Growth Hormone (2017-2022) & (K Units)
Figure 17. G-CSF and G-CSF Biosimilars Consumed in Erythropoietin
Figure 18. Global G-CSF and G-CSF Biosimilars Market: Erythropoietin (2017-2022) & (K Units)
Figure 19. G-CSF and G-CSF Biosimilars Consumed in Monoclonal Antibodies
Figure 20. Global G-CSF and G-CSF Biosimilars Market: Monoclonal Antibodies (2017-2022) & (K Units)
Figure 21. G-CSF and G-CSF Biosimilars Consumed in Insulin
Figure 22. Global G-CSF and G-CSF Biosimilars Market: Insulin (2017-2022) & (K Units)
Figure 23. G-CSF and G-CSF Biosimilars Consumed in Interferon
Figure 24. Global G-CSF and G-CSF Biosimilars Market: Interferon (2017-2022) & (K Units)
Figure 25. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2022)
Figure 26. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application in 2021
Figure 27. G-CSF and G-CSF Biosimilars Revenue Market by Company in 2021 ($ Million)
Figure 28. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Company in 2021
Figure 29. Global G-CSF and G-CSF Biosimilars Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Geographic Region in 2021
Figure 31. Global G-CSF and G-CSF Biosimilars Sales Market Share by Region (2017-2022)
Figure 32. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Country/Region in 2021
Figure 33. Americas G-CSF and G-CSF Biosimilars Sales 2017-2022 (K Units)
Figure 34. Americas G-CSF and G-CSF Biosimilars Revenue 2017-2022 ($ Millions)
Figure 35. APAC G-CSF and G-CSF Biosimilars Sales 2017-2022 (K Units)
Figure 36. APAC G-CSF and G-CSF Biosimilars Revenue 2017-2022 ($ Millions)
Figure 37. Europe G-CSF and G-CSF Biosimilars Sales 2017-2022 (K Units)
Figure 38. Europe G-CSF and G-CSF Biosimilars Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa G-CSF and G-CSF Biosimilars Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa G-CSF and G-CSF Biosimilars Revenue 2017-2022 ($ Millions)
Figure 41. Americas G-CSF and G-CSF Biosimilars Sales Market Share by Country in 2021
Figure 42. Americas G-CSF and G-CSF Biosimilars Revenue Market Share by Country in 2021
Figure 43. United States G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC G-CSF and G-CSF Biosimilars Sales Market Share by Region in 2021
Figure 48. APAC G-CSF and G-CSF Biosimilars Revenue Market Share by Regions in 2021
Figure 49. China G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 53. India G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Country in 2021
Figure 56. Europe G-CSF and G-CSF Biosimilars Revenue Market Share by Country in 2021
Figure 57. Germany G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 58. France G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa G-CSF and G-CSF Biosimilars Sales Market Share by Country in 2021
Figure 63. Middle East & Africa G-CSF and G-CSF Biosimilars Revenue Market Share by Country in 2021
Figure 64. Egypt G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country G-CSF and G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of G-CSF and G-CSF Biosimilars in 2021
Figure 70. Manufacturing Process Analysis of G-CSF and G-CSF Biosimilars
Figure 71. Industry Chain Structure of G-CSF and G-CSF Biosimilars
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
